← Back

Wire · opportunities

Endometriosis can elude diagnosis for years. What to know about the disease and new ways to find it

Published

5 September 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at abcnews.com

Verified

Fusion42 · 5 September 2026 · Fusion42 review

New diagnostic tests for endometriosis used in countries like the UK aim to reduce diagnosis delays but are not yet FDA-approved in the US. These tests could supplement but not replace current diagnostic methods and may improve early detection and treatment planning for sufferers.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ The Wire takeaway

Medtech founders in women’s health should track new diagnostic tests for endometriosis gaining uptake in Europe but awaiting FDA approval. You can now target improved early diagnosis tools as a gap the established methods won’t fill soon.

Coverage

1 source · 5 Sep 2026

Related on Wire

Topics

Medtechendometriosisdiagnostic-testsmedtech-innovationregulatory-approvalwomen-health